No cytotoxic effect was observed on other cancer celllines (HeLa S3, HL60, HepG2) or primary PBMCs for up to 10 μM.We report the first example of the PNP inhibitor exhibiting over 60-foldselectivity for the pathogenic enzyme (MtPNP) overhPNP. This evidence concerns the gene PNP and cancer.